Allergies In-Vitro In-Vivo Regulation 
pharmaphorum
AUGUST 10, 2020
It also includes the phase 3 randomised, placebo-controlled study of Veklury conducted by the National Institute of Allergy and Infectious Diseases (NIAID). The filing with the FDA follows approval by several regulators across the world, including in the European Union and Japan.
The Pharma Data
JANUARY 12, 2021
Dr Graham is a medicines development expert and Infectious Diseases Epidemiologist with global Biotech and Pharma R&D experience in Phase I-IV therapeutics as well as in-vivo & in-vitro diagnostics, across many modalities. He has in depth Global Development Expertise (e.g. Previously, he held roles as CMO at Trimeris Inc.
Expert insights. Personalized for you.
99 
Let's personalize your content